Tevogen Bio Reaffirms That The Form S-1 Filed On June 21, 2024, Which Was Declared Effective By The SEC On August 2, 2024 Does Not Relate To Any Previously Undisclosed New Issuances Of Dilutive Securities
Portfolio Pulse from Benzinga Newsdesk
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) reaffirmed that its Form S-1, declared effective by the SEC on August 2, 2024, does not involve any previously undisclosed new issuances of dilutive securities. The registration statement pertains to earnout shares, shares underlying outstanding warrants, and the resale of shares and warrants by existing securityholders.
August 09, 2024 | 3:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Tevogen Bio's reaffirmation that its Form S-1 does not include new dilutive securities is likely to reassure investors, potentially stabilizing or positively impacting the stock price in the short term.
The confirmation that there are no new dilutive securities in the Form S-1 filing should alleviate investor concerns about potential dilution, which is generally positive for the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100